UBS Group’s PureFunds ETFx HealthTech ETF IMED Stock Holding History

UBS Group’s Portfolio IMED Stock Details IMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-114	Closed	-$3K	–	8304
2017 Q1	$3K	Buy	114 +80	+235%	+$1.97K	﹤0.01%	7247
2016 Q4	$1K	Buy	+34	New	+$818	﹤0.01%	7702

Other funds holding IMED

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group's IMED Position: Q2 2017 in Review

UBS Group sold out of PureFunds ETFx HealthTech ETF (IMED) in Q2 2017, closing a stake of 114 shares — an estimated $3K sold.

UBS Group first reported a position in IMED in Q4 2016 and held it in 2 quarters. The position peaked at $3K in Q1 2017. 2 funds tracked by Wall St. Rank hold IMED as of Q2 2017.

UBS Group reported no remaining PureFunds ETFx HealthTech ETF position as of Q2 2017 after selling out during the quarter.
UBS Group sold 114 PureFunds ETFx HealthTech ETF shares in Q2 2017, an estimated $3K.
UBS Group first reported a position in PureFunds ETFx HealthTech ETF in Q4 2016 and held it in 2 quarters.
UBS Group's PureFunds ETFx HealthTech ETF position peaked at $3K in Q1 2017.
2 funds tracked by Wall St. Rank held PureFunds ETFx HealthTech ETF as of Q2 2017.

Based on UBS Group's 13F filing for Q2 2017, filed 14 Aug 2017.